Market Size of North America Regenerative Medicines Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
Historical Data Period | 2019 - 2022 |
CAGR | 19.50 % |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
North America Regenerative Medicines Market Analysis
The North America Regenerative Medicine Market is expected to register a CAGR of nearly 19.5 % during the forecast period. The key factors propelling the growth of the North America regenerative medicine market are the increasing adoption of stem cell technologies, gene therapies, and tissue engineering, and the technological advancements in regenerative medicine.
As per Heart Disease & Stroke Statistical Fact Sheet 2020, estimates that a minimum of 40,000 infants is expected to be affected each year by congenital heart defects in the United States. Of these, about 25% or 2.4 (per 1,000 live births), require treatment in the first year of life. In addition, according to the Centers for Disease Control and Prevention (CDC), in the United States, the prevalence of atrial fibrillation is estimated to rise to 12.1 million by the year 2030.
Technological advancements in biologics, biomaterials, stem cell technology, and tissue engineering, thus contributing to the market growth. Thus, owing to the above mentioned factors the market is expected to show significant growth over the forecast period.